UnitedHealth Group Incorporated (UNH) Fair Value & Analysis
Healthcare · US · Market cap $384B · ISIN US91324P1021
What is UnitedHealth Group Incorporated really worth?
A solid business, trading 24% below our fair value of $525.71.
Strengths
Risks
For context
Fair value as of: Aug 29, 2026
From 24 valuation models · updated 7 days ago
Fair value updated Aug 29, 2026, revised from $292.06 to $525.71 (+80.0%) since Aug 27, 2026. Share price −1.6% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
- The price sits in the lower half of our model range, the side with the larger margin of safety.
- Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 29, 2026.
How to read this chart
60‑month range $231.57 – $599.78 · fair‑value band $367.96 – $657.13 · the $400.94 price screens below the $525.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Aug 29, 2026.
Analysis
UnitedHealth Group Incorporated (UNH) currently trades at $400.94, while our model-based Fair Value estimate is $525.71, implying the stock looks roughly 23.7% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bull case: the DCF Models group reads highest at a median of $361.66 per share, and 5 of the 24 models we run sit above the $400.94 price. Bear case: the Asset-Based group reads lowest at $69.43, and 19 of the 24 models stay below the price. Evidence for this calculation is medium.
Over the trailing twelve months, UnitedHealth Group Incorporated generated revenue of $450B at a net margin of 2.7%. Revenue grew 2.0% year over year. It earns a return on equity of 12.2%. Net debt stands at $54.0B. Fundamentals as of Aug 29, 2026
Our scenario range runs from $367.96 (bear case) to $657.13 (bull case); at $400.94, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 1% below its 52-week high and 74% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at 31%, UNH screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $3.01 per share, which is 0.6 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 24 models by family
Widest divergence: DCF Models ($361.66) versus Asset-Based ($69.43). Highest evidence: FCF DCF (74).
Notify me when UNH reaches fair value
Put UNH on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 29, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 72
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.
Full company description
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
UnitedHealth Group Incorporated reported revenue of $448B in FY2025 versus $288B in FY2021, a compound +11.7%/yr. Reported net income was $12.1B in FY2025, compounding −8.6%/yr from FY2021.
of which total revenue +11.1 % · buybacks/dilution +0.6 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
Watch UNH: get an alert when its fair value changes →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- UnitedHealth Stock Recovered Before Its Margins Did
- Is UnitedHealth Finally Turning the Corner After a Tough 2025?
- Is UnitedHealth Group (UNH) Finally Turning the Corner Under Stephen Hemsley?
- How Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?
Peer Group
Healthcare Plans · 15 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Healthcare Plans median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Aug 29, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CVS Health Corporation CVS | $93.06 | $42.25 | −55% |
| Elevance Health, Inc ELV | $399.14 | $426.53 | +7% |
| The Cigna Group CI | $276.08 | $495.42 | +79% |
| Humana Inc HUM | $385.54 | $126.42 | −67% |
| Centene Corporation CNC | $64.75 | $111.96 | +73% |
| Molina Healthcare, Inc MOH | $203.06 | $199.31 | −2% |
| Oscar Health, Inc OSCR | $30.93 | $61.86 | +100% |
| Alignment Healthcare, Inc ALHC | $13.52 | $2.37 | −82% |
| Progyny, Inc PGNY | $25.65 | $16.44 | −36% |
| Medi Assist Healthcare Services Limited MEDIASSIST | ₹346.80 | ₹226.12 | −35% |
Compare UnitedHealth Group Incorporated with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is UnitedHealth Group Incorporated (UNH) overvalued or undervalued?
What is the fair value of UNH?
What is the quality score of UNH?
What is the revenue of UnitedHealth Group Incorporated (UNH)?
What is the net profit margin of UNH?
Does UnitedHealth Group Incorporated pay a dividend?
Watch UnitedHealth Group Incorporated in the live analysis
One click puts UnitedHealth Group Incorporated on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.